SCHEDULE 13D

Company

LIFECORE BIOMEDICAL, INC. \DE\

Filed

June 14, 2012

Accession Number

0001144204-12-034882

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →